ArticleCancer management and research2019

First-Line Doublet Chemotherapy for Metastatic Triple-Negative Breast Cancer: Circulating Tumor Cell Analysis of the tnAcity Trial.

Minetta C Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.